SARS-CoV-2 decontamination of skin with disinfectants active during and after application.
J Hosp Infect
; 111: 35-39, 2021 May.
Article
in English
| MEDLINE | ID: covidwho-1122084
ABSTRACT
BACKGROUND:
The coronavirus disease 2019 pandemic has resulted in high levels of exposure of medical workers to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Hand decontamination is one of the actions recommended to reduce the risk of infection.AIM:
Two disinfectants - BIAKOS antimicrobial skin and wound cleanser (AWC) and AWC2 (Sanara MedTech, Fort Worth, TX, USA) - were tested to determine whether they can inactivate SARS-CoV-2 upon contact or as a coating applied before contact with the virus.METHODS:
The ability of AWC and AWC2 to inactivate SARS-CoV-2 was tested in liquid and dried form on plastic surfaces and porcine skin.FINDINGS:
AWC and AWC2 were effective in reducing the infectious titre of SARS-CoV-2 in liquid form during application and in dried form 4 h after application. Virus on skin was reduced up to 2 log10-fold and 3.5 log10-fold after treatment with AWC and AWC2, respectively.CONCLUSION:
Application of AWC and AWC2 to skin reduces the level of SARS-CoV-2 and the risk of infection.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Skin
/
Hand Disinfection
/
Microbial Viability
/
Hand Sanitizers
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Hosp Infect
Year:
2021
Document Type:
Article
Affiliation country:
J.jhin.2021.02.004
Similar
MEDLINE
...
LILACS
LIS